Robert Murray McKinnell

This inventor holds 73 USPTO granted patents and 4 published patent applications and 9 EPO patents, primarily in JAK Inhibitors (CPC class C07D). Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2008-2025.

USPTO Granted Patents = 73 (Patent Applications = 4)

% Patents Active = 28.8

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 364(Granted Patents)

Forward Citations (Not Self Cited) = 101(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Half Moon Bay, CA (US) (2008 - 2014)
South San Francisco, CA (US) (2020 - 2022)
Millbrae, CA (US) (2011 - 2023)

Company Filing History:

Theravance Biopharma R&d IP, LLC

patents

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

JAK Inhibitors

Hepatitis C Virus

Antihypertensive Agents

Imidazolo Indazole

Pyrimidine Compounds

Benzimidazole

Pyrazolo Compounds

Dual-acting Agents

Triazole Compounds

Piperazine

Fused Compounds

Bicyclic Compounds

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384761 - Imidazolo indazole compounds as JAK inhibitors (2025-08-12),

2. 12172994 - Pyrimidine compound as JAK kinase inhibitor (2024-12-24),

3. 11697648 - Fused pyrimidine pyridinone compounds as JAK inhibitors (2023-07-11),

4. 11420965 - Pyrimidine compound as JAK kinase inhibitor (2022-08-23),

5. 11339160 - Imidazole and triazole containing bicyclic compounds as JAK inhibitors (2022-05-24),

6. 11254655 - Benzimidazole-carboxamide compounds as 5-HTreceptor agonists (2022-02-22),

7. 11160810 - Fused imidazo-piperidine JAK inhibitor compound (2021-11-02),

8. 10988470 - Pyrimidine compound as JAK kinase inhibitor (2021-04-27),

9. 10968205 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors (2021-04-06),

10. 10851102 - Imidazole and triazole containing bicyclic compounds as JAK inhibitors (2020-12-01),

11. 10696656 - Benzimidazole-carboxamide compounds as 5-HTreceptor agonists (2020-06-30),

12. 10562894 - Pyrimidine compound as JAK kinase inhibitor (2020-02-18),

13. 10538513 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors (2020-01-21),

14. 10392368 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors (2019-08-27),

15. 10308646 - Pyrimidine compound as JAK kinase inhibitor (2019-06-04),

Title: The Innovative Journey of Robert Murray McKinnell

Introduction:

Robert Murray McKinnell, a visionary inventor based in Millbrae, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents:

McKinnell's latest patents showcase his commitment to innovation, with a focus on cutting-edge technologies in the realm of artificial intelligence and renewable energy sources.

Career Highlights:

Throughout his illustrious career, McKinnell has been at the forefront of technological advancements, leading teams to develop revolutionary products that have reshaped industries. His expertise in engineering and design has led to the creation of products that have improved the lives of many.

Collaborations:

McKinnell is known for his collaborative spirit, having worked with top research institutions, leading companies, and brilliant minds in the field. These collaborations have resulted in groundbreaking inventions that have set new standards in the industry.

Conclusion:

In conclusion, Robert Murray McKinnell's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventions continue to inspire and pave the way for future generations of inventors and innovators.